Compliance of patients with heterozygous familial hypercholesterolemia: 5-year follow-up of the renaissance registry-Reference-Cited by-同舟云学术

Compliance of patients with heterozygous familial hypercholesterolemia: 5-year follow-up of the renaissance registry

Published:2023 Issue:3 Volume:18 Page:35
ISSN:2077-6764
Container-title:Kardiologicheskii vestnik
language:en
Short-container-title:Kardio. vestn.

Author:

Chubykina U.V.^ORCID,Ezhov M.V.^ORCID,Rozhkova T.A.^ORCID,Tamaeva B.M.^ORCID,Sokolov A.A.^ORCID,Ershova A.I.^ORCID,Meshkov A.N.^ORCID,Mikhailina V.I.^ORCID,Blokhina A.V.^ORCID,Limonova A.S.^ORCID,Kopylova O.V.^ORCID,Shaposhnik I.I.^ORCID,Genkel V.V.^ORCID,Gurevich V.S.^ORCID,Urazgildeeva S.A.^ORCID,Tregubov A.V.^ORCID,Muzalevskaya M.V.^ORCID,Voevoda M.I.^ORCID,Timoshchenko O.V.^ORCID,Shakhtshneider E.V.^ORCID,Ragino Yu.I.^ORCID,Sadykova D.I.^ORCID,Slastnikova E.S.^ORCID,Galimova L.F.^ORCID,Kosmacheva E.D.^ORCID,Namitokov A.M.^ORCID,Alieva A.S.^ORCID,Galyavich A.S.^ORCID,Kim Z.F.^ORCID,Korneva V.A.^ORCID,Kuznetsova T.Yu.^ORCID,Filippov A.E.^ORCID,Tuktarov A.M.^ORCID,Vorobyov A.S.^ORCID,Astrakhantseva I.D.^ORCID,Bogdanov D.Yu.^ORCID,Kachkovsky M.A.^ORCID,Egorova A.V.^ORCID,Konstantinov V.O.^ORCID,Serebrenitskaya M.P.^ORCID,Zafiraki V.K.^ORCID,Bizyaeva N.N.^ORCID,Androsyuk N.G.^ORCID,Kiseleva M.A.^ORCID,Grigorieva Yu.G.^ORCID,Korennova O.Yu.^ORCID,Yukhina Yu.E.^ORCID,Devyatova M.D.^ORCID,Isaeva A.V.^ORCID,Ivanova O.N.^ORCID,Vasiliev P.A.^ORCID,Avdeeva I.V.^ORCID,Oleinikov V.E.^ORCID,Vorobieva Yu.A.^ORCID,Ermakova Yu.A.^ORCID,Mukha N.V.^ORCID,Zaitsev D.N.^ORCID,Vasilenko P.A.^ORCID,Zykov M.V.^ORCID,Petelina T.I.^ORCID,Mikova E.V.^ORCID,Bednova S.E.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Family Practice,Cardiology and Cardiovascular Medicine,Surgery,Internal Medicine

Reference19 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

2. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

3. Worldwide Prevalence of Familial Hypercholesterolemia

4. The Prevalence of Heterozygous Familial Hypercholesterolemia in Selected Regions of the Russian Federation: The FH-ESSE-RF Study

5. Familial Hypercholesterolemia: Global Burden and Approaches